Brain iron and ferritin in Parkinson's and Alzheimer's diseases

Ambani LM, van Woert MH, Murphy S (1975) Brain peroxidase and catalase in Parkinson's disease. Arch Neurol 32: 114–118

Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Post mortem distribution of dopamine and homovanillic acid in human brain. Variations related to age, and a review of the literature. J Neural Transm 45: 81–105

Ben-Shachar D, Ashkenazi R, Youdim MBH (1986) Long term consequences of early irondeficiency on dopaminergic neurotransmission Int J Dev Neurosci 4: 81–88

Burns SR, Markey SP, Philips JM, Chuang CC (1984) The neurotoxicity of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) in the monkey and man. Can J Neurol Sci 11: 166–169

Casey JL, Hentze MW, Koeller DM, Caughman SW, Rounault TA, Klausner RD, Harford JB (1988) Iron responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 240: 924–928

Chen JC, Hardy PA, Clauberg M, et al (1989) T2 values in the human brain: comparison with quantitative assays of iron and ferritin. Radiology 173: 521–526

Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1: 249–254

Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD (1987) Increased nigral iron content in postmortem parkinsonian brain Lancet ii: 1219–1220

Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989a) Basal lipid peroxidation substantia nigra is increased in Parkinson's disease. J Neurochem 52: 381–389

Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989b) Increased nigral iron content and alterations in other metal irons occurring in brains in Parkinson's disease. J Neurochem 52: 1830–1836

Dexter DT, Carayon A, Vidailhet M, Ruberg M, Agid F, et al (1990) Decreased ferritin levels in brain in Parkinson's disease. J Neurochem 55: 16–20

Drayer BP, Burger P, Darwin R, et al (1986a) Magnetic resonance imaging of brain iron. AJNR 7: 373–380

Brayer BP, Olanow W, Burger P, et al (1986b) Parkinson plus syndrome diagnosis using high field MR imaging of brain iron. Radiology 159: 493–498

Dwork AJ, Lawler G, Zybert PA, Durkin W, Osman M, Wilson N, Barkai AI (1990) An autoradiographic study of the uptake and distribution of iron by the brain of young rat. Brain Res (in press)

Earle KM (1968) Studies on Parkinson's disease including X-ray fluorescent spectroscopy of formalin fixed brain tissue. J Neuropathol Exp Neurol 27: 1–14

Fischer P, Gatterer G, Simanyi M, Jellinger K, Marterer A, Danielczyk K, Danielzcyk W (1990) Memory deficits in advanced Parkinson's disease. J Neural Transm (PD-Sect) 2: 59–70

Forno LS (1983) Pathology of Parkinson's disease. In: Marsden CD, Fahn ST (eds) Movement disorders I. Butterworths, London, pp 25–40

Fleming J, Joshi JP (1987) Ferritin: isolation of aluminium-ferritin complex from brain. Proc Natl Acad Sci USA 84: 7866–7870

Gerber MR, Connor JR (1989) Do oligodendrocytes mediate iron regulation in human brain? Neurology 26: 95–98

Gomori G (1936) Microtechnical demonstration of iron. Am J Pathol 12: 655–663

Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG (1990) Ferritin as a component of the neurotic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl) 81 (in press)

Gutteridge JMC, Halliwell B, Treffry A, Harrison PM, Blake D (1983) Effect of ferritin containing fractions with different iron loading on lipid peroxidation. Biochem J 209: 557–560

Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41–51

Halliwell B, Gutteridge JMC (1986) Iron and free radical reactions: two aspects of antioxidant protection. Trends Biochem Sci 11: 1372–1375

Heikkila RE, Nicklas WJ, Duvoisin RC (1986) Studies on the mechanism of MPTP-MPP+-induced neurotoxicity in rodents. In: Markey, SP, Castagnoli N Jr, Trevor A, Kopin IJ (eds) MPTP: a neurotoxin producing a parkinsonian syndrome. Academic Press, Orlando San Diego New York Austin Boston London Sidney Tokyo Toronto, pp 69–83

Hentze MW, Caugham SW, Rouault TA, Barriolanal JG, Dancis A, Harford JB, Klausner RD (1987) Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238: 1570–1573

Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427–443

Iacopino AM, Christakos S (1990) Specific reduction of calcium-binding protein (28-kilo-dalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 87: 4078–4082

Jellinger K, Danielczyk W, Fischer P, Gabriel E (1990a) Clinico-pathological analysis of dementia disorders in the elderly. J Neurol Sci 95: 239–258

Jellinger K, Lassmann H, Fischer P, Danielczyk W (1990b) Validation of diagnostic criteria for Alzheimer's disease. Neurobiol Aging 11: 126

Joshi JC, Clauberg M (1988) Ferritin; an iron storage protein with diverse functions. BioFactors 1: 207–212

Joshi JG, Fleming J, Lassmann H, Iqbal K, Grundke-Iqbal I (1990) Accumulation of ferritin in Alzheimer disease (AD) brain. Neurobiol Aging 11: 216–217

Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K (1989) Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol (Berl) 79: 129–136

Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42: 1097–1105

Kish SJ, Morito C, Hornykiewicz O (1985) Glutathione peroxidase activity in Parkinson's disease brain. Neurosci Lett 58: 343–346

Langston JW, Forno LS, Rebert CD, Irwin I (1984) Selective nigra toxicity after systemic administration of MPTP in the squirrel monkey. Brain Res 292: 390–394

McKhann G, Drachman D, Fostein M, Katzman R, Price D, Stadlan E (1984) Clinical diagnosis of Alzheimer's disease. Report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939–944

McGeer PL, Itagaki S, Akiyama H, McGeer EG (1988a) Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol 24: 574–576

McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988b) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285–1291

Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450–1455

Octave JN, Schneider YJ, Trouet A, Crichton RR (1983) Iron uptake and utilization by mammalian cells. I. Cellular uptake of transferrin and iron. Trends Biochem Sci 8: 217–220

Reichmann H, Riederer P (1989) Biochemische Analyse des Atmungskettenkomplexes verschiedener Hirnregionen von Patienten mit M. Parkinson. In: Oertel H (Hrsg) Morbus Parkinson und andere Basalganglienerkrankungen. BMFT Symposium Bad Kissingen, S 44

Riederer P, Jellinger K, Seemann D (1984) Monoamine oxidase and parkinsonism. In: Tipton KF, Dostert P, Strolin-Benedetti (eds) Monoamine oxidase and disease. Academic Press, London Orlando San Diego New York Toronto Montreal Sidney Tokyo, pp 403–415

Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520

Rozemuller JM, Eikelenboom P, Pals ST, Stam FC (1989) Microglia cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 101: 288–292

Rutledge JN (1988) Magnetic resonance of movement disorders. In: Jankovic J, Tolosa E (eds) Parkinson's disease and movement disorders. Urban and Schwarzenberg, Baltimore Munich, pp 441–459

Schapira AHV, Cooper JM, Dexter D, Jenner P, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet i: 1269

Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MBH (1988) Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain. J Neural Transm 74: 199–205

Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J Neurochem (in press)

Sternberger LA, Hardy PH, Cuculis JJ, Meyer HG (1970) The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradisch peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 18: 315–333

Theil EC (1987) Ferritin; structure, gene regulation, and cellular function in animals, plants and microorganisms. Annu Rev Biochem 56: 289–315

Tierney MC, Fisher RH, Lewis AJ, et al (1988) The NINDCS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease. A clinicopathologic study of 57 cases. Neurology 38: 359–364

White K, Munro HN (1988) Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J Biol Chem 263: 8938–8942

Youdim MBH, Ben-Shachar D, Riederer P (1989) Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 126: 47–54

Youdim MBH, Ben-Schachar D, Yehuda S, Riederer P (1990) The role of iron in the basal ganglia. Adv Neurol 53: 153–216

Zaleska MH, Nagy K, Floyd RA (1989) Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes. Neurochem Res 14: 597–605